First Eagle Investment Management LLC Lowers Position in DENTSPLY SIRONA Inc. $XRAY

First Eagle Investment Management LLC trimmed its position in shares of DENTSPLY SIRONA Inc. (NASDAQ:XRAY) by 1.7% during the second quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 14,193,858 shares of the medical instruments supplier’s stock after selling 245,117 shares during the quarter. First Eagle Investment Management LLC owned 7.12% of DENTSPLY SIRONA worth $225,398,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other large investors also recently made changes to their positions in the company. Bastion Asset Management Inc. purchased a new position in DENTSPLY SIRONA during the second quarter worth about $4,825,000. Savant Capital LLC lifted its position in shares of DENTSPLY SIRONA by 12.4% during the 2nd quarter. Savant Capital LLC now owns 129,234 shares of the medical instruments supplier’s stock worth $2,052,000 after buying an additional 14,271 shares in the last quarter. Bank of Montreal Can boosted its stake in shares of DENTSPLY SIRONA by 8.2% in the 2nd quarter. Bank of Montreal Can now owns 352,524 shares of the medical instruments supplier’s stock worth $5,598,000 after buying an additional 26,610 shares during the last quarter. Retirement Systems of Alabama grew its holdings in shares of DENTSPLY SIRONA by 0.7% in the second quarter. Retirement Systems of Alabama now owns 243,581 shares of the medical instruments supplier’s stock valued at $3,868,000 after acquiring an additional 1,641 shares in the last quarter. Finally, Y Intercept Hong Kong Ltd increased its position in shares of DENTSPLY SIRONA by 377.0% during the second quarter. Y Intercept Hong Kong Ltd now owns 238,131 shares of the medical instruments supplier’s stock valued at $3,782,000 after acquiring an additional 188,205 shares during the last quarter. 95.70% of the stock is owned by institutional investors.

Analyst Upgrades and Downgrades

Several research analysts have weighed in on the company. Wall Street Zen cut DENTSPLY SIRONA from a “buy” rating to a “hold” rating in a research report on Saturday, October 18th. Wells Fargo & Company cut their price target on shares of DENTSPLY SIRONA from $16.00 to $15.00 and set an “equal weight” rating on the stock in a report on Friday, August 8th. Weiss Ratings restated a “sell (d-)” rating on shares of DENTSPLY SIRONA in a report on Wednesday, October 8th. UBS Group lowered their price objective on shares of DENTSPLY SIRONA from $24.00 to $23.00 and set a “buy” rating on the stock in a research report on Tuesday, October 28th. Finally, Needham & Company LLC reissued a “hold” rating on shares of DENTSPLY SIRONA in a research report on Friday, September 26th. Two research analysts have rated the stock with a Buy rating, nine have assigned a Hold rating and one has issued a Sell rating to the stock. According to data from MarketBeat.com, the stock has a consensus rating of “Hold” and a consensus target price of $17.55.

DENTSPLY SIRONA Price Performance

NASDAQ XRAY opened at $11.02 on Friday. The company has a quick ratio of 1.11, a current ratio of 1.69 and a debt-to-equity ratio of 1.13. The company has a market cap of $2.20 billion, a PE ratio of -2.32, a price-to-earnings-growth ratio of 0.81 and a beta of 1.00. DENTSPLY SIRONA Inc. has a 52 week low of $10.69 and a 52 week high of $20.59. The firm’s 50-day simple moving average is $13.04 and its two-hundred day simple moving average is $14.48.

DENTSPLY SIRONA (NASDAQ:XRAY) last announced its quarterly earnings results on Thursday, November 6th. The medical instruments supplier reported $0.37 EPS for the quarter, missing analysts’ consensus estimates of $0.45 by ($0.08). The business had revenue of $904.00 million for the quarter, compared to analysts’ expectations of $900.33 million. DENTSPLY SIRONA had a negative net margin of 25.85% and a positive return on equity of 16.33%. The business’s quarterly revenue was down 4.9% compared to the same quarter last year. During the same quarter in the previous year, the company posted $0.50 earnings per share. DENTSPLY SIRONA has set its FY 2025 guidance at 1.600-1.600 EPS. Research analysts predict that DENTSPLY SIRONA Inc. will post 1.84 earnings per share for the current year.

DENTSPLY SIRONA Profile

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.